{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0173-0869",
      "generic_name": "umeclidinium bromide and vilanterol trifenatate",
      "labeler_name": "GlaxoSmithKline LLC",
      "brand_name": "Anoro Ellipta",
      "active_ingredients": [
        {
          "name": "UMECLIDINIUM BROMIDE",
          "strength": "62.5 ug/1"
        },
        {
          "name": "VILANTEROL TRIFENATATE",
          "strength": "25 ug/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0173-0869-06",
          "description": "1 TRAY in 1 CARTON (0173-0869-06)  / 1 INHALER in 1 TRAY / 7 POWDER in 1 INHALER",
          "marketing_start_date": "20140131",
          "sample": false
        },
        {
          "package_ndc": "0173-0869-10",
          "description": "1 TRAY in 1 CARTON (0173-0869-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
          "marketing_start_date": "20140131",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "rxcui": [
          "1487519",
          "1487524",
          "1487527",
          "1487528"
        ],
        "spl_set_id": [
          "2dbd0671-c565-40c5-bf0f-e324db26799c"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "7AN603V4JV",
          "40AHO2C6DG"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "POWDER",
      "spl_id": "90be6e26-9d2d-4b9d-8378-5e38c3076720",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "RESPIRATORY (INHALATION)"
      ],
      "marketing_start_date": "20140131",
      "product_id": "0173-0869_90be6e26-9d2d-4b9d-8378-5e38c3076720",
      "application_number": "NDA203975",
      "brand_name_base": "Anoro Ellipta",
      "pharm_class": [
        "Adrenergic beta2-Agonists [MoA]",
        "Anticholinergic [EPC]",
        "Cholinergic Antagonists [MoA]",
        "beta2-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}